We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+3.01%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$3.84B
AUM Growth
+$272M
Cap. Flow
+$189M
Cap. Flow %
4.93%
Top 10 Hldgs %
20.07%
Holding
671
New
230
Increased
99
Reduced
90
Closed
234

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$103M
2
MMM icon
3M
MMM
+$64.5M
3
SNN icon
Smith & Nephew
SNN
+$51.4M
4
MOD icon
Modine Manufacturing
MOD
+$47.9M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$40.9M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.46%
2 Industrials 14.61%
3 Technology 10.28%
4 Healthcare 8.88%
5 Communication Services 7.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
V icon
201
Visa
V
$684B
$4.4M 0.11%
+13,915
New +$4.18M
PETS icon
202
PUT
PetMed Express
PETS
$41.7M
$4.34M 0.11%
+900,000
New +$4.22M
SCPH
203
DELISTED
scPharmaceuticals
SCPH
$4.32M 0.11%
1,219,127
-160,866
-12% -$616K
GPI icon
204
Group 1 Automotive
GPI
$3.42B
$4.29M 0.11%
+10,171
New +$4.02M
IHI icon
205
iShares US Medical Devices ETF
IHI
$3.13B
$4.28M 0.11%
73,338
-6,285
-8% -$374K
REGN icon
206
CALL
Regeneron Pharmaceuticals
REGN
$78.5B
$4.27M 0.11%
+6,000
New +$5.04M
TSCO icon
207
CALL
Tractor Supply
TSCO
$16.1B
$4.24M 0.11%
+80,000
New +$4.52M
HSY icon
208
PUT
Hershey
HSY
$35.2B
$4.23M 0.11%
+25,000
New +$4.48M
OPLN
209
Openlane
OPLN
$4.21B
$4.17M 0.11%
210,293
+133,567
+174% +$2.46M
ACI icon
210
Albertsons Companies
ACI
$5.62B
$4.09M 0.11%
208,119
-31,881
-13% -$605K
IYR icon
211
iShares US Real Estate ETF
IYR
$4.66B
$4.06M 0.11%
43,581
-9,137
-17% -$900K
GENI icon
212
CALL
Genius Sports
GENI
$1.85B
$3.97M 0.1%
459,500
-1,126,100
-71% -$9.4M
ITB icon
213
iShares US Home Construction ETF
ITB
$2.26B
$3.97M 0.1%
38,378
+13,451
+54% +$1.6M
BTU icon
214
Peabody Energy
BTU
$2.6B
$3.94M 0.1%
+188,256
New +$4.65M
STX icon
215
Seagate
STX
$194B
$3.88M 0.1%
+45,000
New +$4.53M
WH icon
216
Wyndham Hotels & Resorts
WH
$5.56B
$3.77M 0.1%
+37,379
New +$3.47M
CRMD icon
217
CorMedix
CRMD
$591M
$3.7M 0.1%
457,320
+314,880
+221% +$3.14M
NSLR
218
Neostellar Capital Corp
NSLR
$269M
$3.59M 0.09%
+610,812
New +$3.12M
MAX icon
219
MediaAlpha
MAX
$758M
$3.51M 0.09%
311,125
-155,302
-33% -$2.23M
IART icon
220
Integra LifeSciences
IART
$1.29B
$3.46M 0.09%
152,452
-102,826
-40% -$2.24M
BURL icon
221
Burlington
BURL
$23.2B
$3.45M 0.09%
+12,119
New +$3.27M
WMT icon
222
Walmart Inc
WMT
$885B
$3.44M 0.09%
38,118
+34,270
+891% +$2.97M
AXSM icon
223
CALL
Axsome Therapeutics
AXSM
$11.2B
$3.44M 0.09%
+40,700
New +$3.74M
VRDN icon
224
Viridian Therapeutics
VRDN
$2.09B
$3.44M 0.09%
+179,496
New +$3.9M
NVO
225
CALL
Novo Nordisk
NVO
$208B
$3.44M 0.09%
40,000
-70,000
-64% -$7.57M

Similar funds

J. Goldman & Co's Q4 2024 Portfolio in Review

As of Q4 2024, J. Goldman & Co held 671 positions worth $3.84B, up 7.6% from $3.56B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

J. Goldman & Co deployed $189M of net new capital in Q4 2024, opening 230 new positions and adding to 99 existing holdings. Its largest new stake was 3M: 491,679 shares worth $63.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 10% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $67.4M trimmed.

  • J. Goldman & Co's largest Q4 2024 buy was 3M: 491,679 shares worth $63.5M.
  • J. Goldman & Co added most to Walt Disney in Q4 2024, an estimated $103M increase.
  • J. Goldman & Co's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $67.4M.
  • J. Goldman & Co fully exited Comcast in Q4 2024, selling an estimated $79.7M.
  • J. Goldman & Co's ten largest holdings make up 20% of its $3.84B portfolio in Q4 2024.
  • J. Goldman & Co opened 230 new positions and closed 234 in Q4 2024.
  • J. Goldman & Co's portfolio value rose 7.6% quarter-over-quarter to $3.84B.

Based on J. Goldman & Co's 13F filing for Q4 2024, filed 14 Feb 2025.